Allogenetics GmbH, a pioneering firm dedicated to transforming organ transplantation technology, has successfully secured significant funding recently. Although the exact amount raised remains undisclosed, the investment comes from a consortium of renowned investors who share a common vision of revolutionizing the way organ transplants are approached and performed. With this funding, Allogenetics aims to accelerate its research and development efforts, particularly in enhancing tissue compatibility and reducing organ rejection rates among transplant recipients. This crucial financial backing will enable the company to enhance its innovative technologies and expand its development team, thereby speeding up the timeline for bringing its groundbreaking solutions to market. The potential impact of Allogenetics' advancements in organ transplantation could save countless lives and significantly improve the quality of life for those suffering from organ failure. The company's commitment to pushing the boundaries of medical science is unwavering, and with the support of its esteemed investors, Allogenetics is poised to make a lasting difference in the field of transplant medicine. For more information about Allogenetics GmbH and its pioneering work, please contact us directly. The future of organ transplantation is brighter than ever, thanks to forward-thinking organizations like Allogenetics, as they continue to lead the charge towards more effective and sustainable solutions in healthcare.
Allogenetics GmbH Secures Major Funding to Revolutionize Organ Transplantation Technology
Get the full Allogenetics GmbH company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Centricity WealthTech
Founded in January 2022, Centricity helps empower finance and investment professionals aspiring to establish their independent practices. The platform aims to deliver a comprehensive SAAS based investment management platform including digital transactional capabilities for a diversified product suite. Wealth management professionals prefer focusing on their clients’ interests and not their employers ever-changing priorities. Also, clients want stability and not a relentless institutional product push. We are looking to bring in consistency of the family office experience for a spectrum of investors across emerging affluent, affluent and high net worth categories. We are boutique by design and an institution by default.
$30.0M Series a
today
MigmaAI
Create, design and send on-brand emails in seconds.
$330.0K Pre-seed
today
Multiverse
Multiverse is the upskilling platform for AI and tech adoption. We’ve built a new model for transforming today’s workforce by combining expert human coaching with AI. Our learning drives real business impact and helps organisations close critical skills gaps - especially in data, AI and all things tech. We’ve already partnered with over 1,500 global organisations to transform their workforce through tech skills. Trusted by Microsoft, Mars, John Lewis Partnership and many more to upskill their team and unlock people’s potential and output. In 2022, we raised our $220m Series D funding - one of the largest venture rounds in EdTech history. We’re proud to be backed by some of the world’s biggest investors, including General Catalyst, Lightspeed Venture Partners and StepStone Group.
$70.0M Unknown
today
SWELL Sculpture Festival
SWELL Sculpture Festival (SWELL) is a multifaceted arts organisation that connects people, art, and place, based in Currumbin, Gold Coast, Queensland. Since 2003 SWELL has exhibited 873 Sculptures in the main exhibition on Currumbin Beach with a portfolio value worth $15.5M.
$5.5K Grant
today
Parcel Health
Healthcare and pharmacies' supply chain runs on expensive plastic. Billions of units of disposable, single-use supplies and packaging — most of it never questioned, never redesigned, never replaced. Paid for at a premium to budgets and to the environment. Until now. Parcel Health is reimagining healthcare supplies, creating products that can protect people and preserve the planet, all at an affordable price point. Tully Tube® is the world's first and only paper pill bottle that meets U.S. regulatory requirements. It is trusted by leading hospital health-systems like Dartmouth-Hitchcock Health System, Allegheny Health Network, and Wellstar Health System. This is just the beginning. Parcel Health is building a future where healthcare supplies are safer for patients, better for the planet, and easier on budgets.
$1.2M Seed
today